Modelling the relationship between antibody-dependent enhancement and immunological distance with application to dengue

Journal of Theoretical Biology

Volumn 242, Issue 2, 2006, Pages 337-346

  Adams, Ben ^a   Boots, Michael ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Antibody dependent enhancement; Dengue; Mathematical model; Serological distance

Indexed keywords

ANTIBODY; DENGUE FEVER; DISEASE TRANSMISSION; MATHEMATICAL ANALYSIS; MORTALITY; RISK ASSESSMENT;

ANTIBODY DEPENDENT ENHANCEMENT; ARTICLE; CROSS REACTION; DENGUE; DISEASE TRANSMISSION; EPIDEMIC; INFECTION SENSITIVITY; MORTALITY; PRIORITY JOURNAL; SEROTYPE; VIRUS STRAIN;

ANTIBODY-DEPENDENT ENHANCEMENT; CROSS REACTIONS; DENGUE HEMORRHAGIC FEVER; DENGUE VIRUS; DISEASE SUSCEPTIBILITY; HUMANS; MODELS, IMMUNOLOGICAL; VIRULENCE;

DENGUE VIRUS;

EID: 33747199584     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2006.03.002     Document Type: Article

References (28)

1. Anderson R.M., and May R.M. Infectious Diseases of Humans. Dynamics and Control (1991), Oxford University Press, Oxford
2. Cologna R., and Rico-Hesse R. American genotype structures decrease dengue virus output from human monocytes and dendritic cells. J. Virol. 77 7 (2003) 3929-3938
3. Cummings D.A.T., Schwartz I.B., Billings L., Shaw L.B., and Burke D.S. Dynamic effects of antibody-dependent enhancement on the fitness of viruses. Proc. Natl Acad. Sci. USA 102 42 (2005) 15259-15264
4. Diamond M.S., Edgil D., Roberts T.G., Lu B., and Harris E. Infection of human cells by dengue virus is modulated by different cell types and viral strains. J. Virol. 74 17 (2000) 7814-7823
5. Ferguson N.M., Anderson R.M., and Gupta S. The effect of antibody-dependent enhancement on the transmission dynamics and persistence of multiple-strain pathogens. Proc. Natl Acad. Sci. USA 96 2 (1999) 790-794
6. Ferguson N.M., Donnelly C.A., and Anderson R.M. Transmission dynamics and epidemiology of dengue: insights from age-stratified sero-prevalence surveys. Philos. Trans. Roy. Soc. London Ser. B 354 (1999) 757-768
7. Foster J.E., Bennett S.N., Carrington C.V.F., Vaughan H., and McMillan W.O. Phylogeography and molecular evolution of dengue 2 in the Caribbean basin, 1981-2000. Virology 324 (2004) 48-59
8. Grenfell B.T., Pybus O.G., Gog J.R., Wood J.L.N., Daly J.M., Mumford J.A., and Holmes E.C. Unifying the epidemiological and evolutionary dynamics of pathogens. Science 303 (2004) 327-332
9. Halstead S.B. Epidemiology of dengue and dengue hemorrhagic fever. In: Gubler D.J., and Kuno G. (Eds). Dengue and Dengue Hemorrhagic Fever (1997), CABI Publishing
10. Holmes E.C. The phylogeography of human viruses. Mol. Ecol. 13 (2004) 745-756
11. Holmes E.C., and Twiddy S.S. The origin, emergence and evolutionary genetics of dengue virus. Infection, Genetics and Evolution 3 (2003) 19-28
12. Janeway C.A., Travers P., Walport M., and Capra J.D. Immunobiology: The Immune System in Health and Disease. fourth ed (1999), Elsevier Science Ltd/Garland Publishing, New York
13. Kawaguchi I., Sasaki A., and Boots M. Why are dengue virus serotypes so distantly related? Enhancement and limiting serotype similarity between dengue virus strains. Proc. Roy. Soc. London Ser. B 270 (2003) 2241-2247
14. Kliks S.C., Nimmanitya S., Nisalak A., and Burke D.S. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am. J. Trop. Med. Hyg. 38 2 (1988) 411-419
15. Kuno G. Factors influencing the transmission of dengue viruses. In: Gubler D.J., and Kuno G. (Eds). Dengue and Dengue Hemorrhagic Fever (1997), CABI Publishing
16. Mady B.J., Erbe D.V., Kurane I., Fanger M.W., and Ennis F.A. Antibody-dependent enhancement of dengue virus infection mediated by bispecific antibodies against cell surface molecules other than Fcγ receptors. J. Immunol. 147 (1991) 3139-3144
17. McBride W.J.H., and Bielefelt-Ohmann H. Dengue viral infections; pathogenesis and epidemiology. Microbes Infect. 2 (2000) 1041-1050
18. Messer W.B., Gubler D.J., Harris E., Sivananthan K., and de Silva A.M. Emergence and global spread of a dengue serotype 3, subtype III virus. Emerg. Infect. Dis. 9 7 (2003) 800-809
19. Nisalak A., et al. Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999. Am. Soc. Trop. Med. Hyg. 68 2 (2003) 191-202
20. Rothman A.L. Dengue: defining protective versus pathologic immunity. J. Clin. Invest. 113 7 (2004) 946-951
21. Rothman A.L., and Ennis F.A. Immunopathogenesis of dengue hemorrhagic fever. Virology 257 (1999) 1-6
22. Stephens H.A.F., et al. HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. Tissue Antigens 60 (2002) 309-318
23. Takada A., and Kawaoka Y. Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications. Rev. Med. Virol. 13 (2003) 387-398
24. Travassos da Rosa A.P.A., et al. Dengue epidemic in Belém, Pará, Brazil, 1996-97. Emerg. Infect. Dis. 6 3 (2000) 298-301
25. Twiddy S.S., Farrar J.J., Vinh Chau N., Willis B., Gould E.A., Gritsum T., Lloyd G., and Holmes E.C. Phylogenetic relationships and differential selection presssure among genotypes of dengue-2 virus. Virology 298 (2002) 63-72
26. Vaughn D.W., et al. Dengue viremia titer, antibody response pattern and virus serotype correlate with disease severity. J. Infect. Dis. 181 (2000) 2-9
27. Watts D.M., Porter K.R., Putvatana P., Vasquez B., Calampa C., Hayes C.G., and Halstead S.B. Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever. The Lancet 354 (1999) 1431-1434
28. WHO, 2002. Dengue and dengue haemorrhagic fever. World Heath Organization Fact Sheet No. 117.